Jane Street
IMVT icon

Jane Street’s Immunovant IMVT Stock Holding History

Jane Street’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$308K Sell
8,000
-28,500
-78% -$868K ﹤0.01% 9159
2026
Q1 		$907K Buy
36,500
+16,600
+83% +$430K ﹤0.01% 6722
2025
Q4 		$506K Sell
19,900
-51,100
-72% -$1.14M ﹤0.01% 7667
2025
Q3 		$1.14M Buy
71,000
+38,400
+118% +$622K ﹤0.01% 6020
2025
Q2 		$522K Sell
32,600
-145,000
-82% -$2.19M ﹤0.01% 6842
2025
Q1 		$3.04M Buy
177,600
+51,800
+41% +$1.08M ﹤0.01% 3699
2024
Q4 		$3.12M Sell
125,800
-54,100
-30% -$1.53M ﹤0.01% 3377
2024
Q3 		$5.13M Buy
179,900
+61,200
+52% +$1.8M ﹤0.01% 2824
2024
Q2 		$3.13M Buy
118,700
+54,900
+86% +$1.56M ﹤0.01% 3743
2024
Q1 		$2.06M Sell
63,800
-58,900
-48% -$2.15M ﹤0.01% 4069
2023
Q4 		$5.17M Sell
122,700
-263,200
-68% -$9.69M ﹤0.01% 2798
2023
Q3 		$14.8M Buy
+385,900
New +$8.72M ﹤0.01% 1372
2022
Q1 		– Sell
-12,500
Closed -$107K – 10645
2021
Q4 		$107K Sell
12,500
-69,900
-85% -$577K ﹤0.01% 9213
2021
Q3 		$716K Sell
82,400
-6,700
-8% -$60.4K ﹤0.01% 6597
2021
Q2 		$942K Buy
+89,100
New +$1.24M ﹤0.01% 5967

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street's IMVT Position: Q2 2026 in Review

Jane Street sold out of Immunovant (IMVT) in Q2 2026, closing a stake of 84,312 shares — an estimated $2.57M sold.

Jane Street first reported a position in IMVT in Q1 2020 and held it in 21 quarters. The position peaked at $25.9M in Q4 2023. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Jane Street reported no remaining Immunovant position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 84,312 Immunovant shares in Q2 2026, an estimated $2.57M.
  • Jane Street first reported a position in Immunovant in Q1 2020 and held it in 21 quarters.
  • Jane Street's Immunovant position peaked at $25.9M in Q4 2023.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.